期刊文献+

莫西沙星治疗老年人下呼吸道感染40例 被引量:7

Treatment of Lower Respiratory Tract Infection by Moxisacin 40 Cases
下载PDF
导出
摘要 目的 观察莫西沙星 (拜复乐 )片剂治疗老年人下呼吸道感染的疗效及安全性。方法 莫西沙星4 0 0mg口服 ,每日 1次 ,5~ 7天为 1个疗程。结果 临床总有效率 95 % ,细菌清除率 83% ,不良反应发生率为5 %。结论 口服莫西沙星治疗老年人呼吸道感染安全有效。 Objective To observe the effect and safety of Moxisacin (Baifule) tablet in treating senile lower respiratory tract infection. Methods Moxisacin 400mg taken orally, once a day, one treatment course 5~7days.Results The total effective rate is 95%, bacteria clearance rate is 83%, side reaction occurance rate is 5%.Conclusion Moxisaxin is effective and safe in treating senile lower respiratory tract infection.
出处 《医药论坛杂志》 2004年第11期25-26,共2页 Journal of Medical Forum
关键词 莫西沙星 治疗 老年人 下呼吸道感染 氟喹诺酮类 抗菌药物 安全性 Moxisacin Lower respiratatony tract infection Senile
  • 相关文献

参考文献6

  • 1DalhoffA, Petersenu, Endremann R. Invitro activity of BAY12 -8039, a new 8 -methoxyquinolone. Chemotherapy, 1996,42:410-25.
  • 2Woodcock JM, Anerews JM, Boswell FJ, et al. In vitro activity of BAY 12-8039, a new fluoroguinolone. Antimicrob Agents Chemother, 1997,41 : 101-1.
  • 3MacGowan AP, Bowker KE, Holt HA, et al. BAY 12-8039, a new 8 - methoxyquindone:comparative in vitro activity with nine other antimicrobials against anaerobic. J Antimicrob Chemother, 1997,40:503-9.
  • 4Riickdeschel G, Dalhoff A. The in vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results. J Antimicrob Chemother, 1999,43 Suppl. B:25-9.
  • 5Bebear CM, Renaudin H, Boudjadja A ,et al. In vitro activity of BAY 12 - 8039, a new fluoroguinolone, against my, coplasmas, Antimicrob Agents Chemother, 1998,42:703-4.
  • 6Barman BJA,Wiseman LR. Moxifloxacin. J Drugs,1999,57 (3) :363-373.

同被引文献45

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部